John Reji Malayil Kuchentungu

John Reji Malayil Kuchentungu

Director Director DIN 03498549
DIN 03498549 First appointment Apr 2011 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Apr 2011
Shareholding value β€’β€’β€’β€’ Premium profile

About John Reji Malayil Kuchentungu

Data last updated:

John Reji Malayil Kuchentungu was a Director at Izen Biosciences Private Limited (2011–2016) and Director at Teckbond Pharma Chem Private Limited (from 2013). The companies operate in Pharma.

DIN 03498549
Primary Designation Director
Industry Pharma
First Appointment 22 Apr 2011
Oldest Company Age 13 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Izen Biosciences Private Limited U24232TG2011PTC074011
Director22 Apr 20112011₹10.49 Cr (FY 2015)Active
Teckbond Pharma Chem Private Limited U24100TG2013PTC089536
Director14 Aug 20132013Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Teckbond Pharma Chem Private Limited
Izen Biosciences Private Limited
Premium access

Shareholding and investment profile for John Reji Malayil Kuchentungu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about John Reji Malayil Kuchentungu

John Reji Malayil Kuchentungu was first appointed on 22 Apr 2011 as Director at Izen Biosciences Private Limited. The most recent appointment on record is 14 Aug 2013 at Teckbond Pharma Chem Private Limited.

John Reji Malayil Kuchentungu held 2 earlier board appointments: Izen Biosciences Private Limited (Director, 22 Apr 2011 to 18 Aug 2016); Teckbond Pharma Chem Private Limited (Director, from 14 Aug 2013).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available